A new study out of Stanford has presented the strongest evidence to date that a common vaccine could significantly reduce the ...

G etting vaccinated for the viral illness shingles, which causes a painful rash, could potentially be the next best tool in ...

The shingles vaccine, typically administered to fend off a painful rash, might pack an unexpected benefit by delaying or even ...

A recent study found that people who received Zostavax, a older shingles vaccine, had a lower risk of developing dementia.

A large natural experiment shows that the herpes zoster vaccine reduces dementia diagnoses by 20% over seven years. The ...

A study of over 280,000 adults found that the shingles vaccine reduced dementia risk by 20%, with a stronger effect in women.

A new study is part of a growing body of evidence that vaccination against shingles—and potentially other infections—can be ...

It makes sense to include routine adult vaccinations to our list of preventative measures, not only for prevention of common infections, but also for dementia prevention. We are living at a time when ...

recombinant zoster vaccine maker GSK said it will partner with the U.K. Dementia Research Institute and Health Data Research U.K. on a long-term project to explore the role of the shingles vaccine ...

Analysis of a Welsh program offering live-attenuated shingles vaccines to people born after a certain date showed a 20 percent relative drop in dementia risk.

The strongest set of evidence to date indicates that people who had a shingles vaccine had significantly lower odds of ...

The vaccine for varicella-zoster virus, commonly known as shingles, could do far more than just protecting people from a rash ...